A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
26 Sep 2026 · 07:54 CST Terminal Access 终端入口 →
000661.SZ深圳证券交易所 · 主板 Main

Changchun High-Tech Industry 长春高新

Biologics 生物制品
¥70.85−¥2.40 · −3.28%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥72.80
High 最高
¥73.20
Low 最低
¥70.70
Prev Close 昨收
¥73.25
Volume 成交量
459.2万股
Turnover 成交额
¥3.28亿
Mkt Cap 总市值
¥289亿
P/E 市盈率
−82.0×
Recent Activity 近期动态All Filings 全部公告 →

18 significant filings since 29 May 2026: 15 on equity incentive, 2 on major contract or bid won and 1 on earnings pre-announcement. The latest, on 12 Sep 2026: 关于2026年限制性股票激励计划首次授予登记完成的公告.
自 29 May 2026 起有 18 份重大公告:equity incentive 15 份、major contract or bid won 2 份、earnings pre-announcement 1 份。最新一份(12 Sep 2026):关于2026年限制性股票激励计划首次授予登记完成的公告。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥136.03 · Low 最低 ¥62.80
708090100110120130
Volume 成交量
3,319.1万
Sep 25Dec 25Mar 26Jun 26Sep 26
Last Twelve Months 近十二个月
3 reports from 3 brokers · 1 unrated 3 家券商 3 份研报,1 份无评级
Reports Share Market
Buy 买入 2 100.0% 70.7%
Outperform 增持 0 0.0% 28.6%
Neutral 中性 0 0.0% 0.7%
Underperform 减持 0 0.0% 0.0%
Sell 卖出 0 0.0% 0.0%

The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平:同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.

Rating Changes 评级变动
10 up · 5 down in all reports held 全部研报中上调 10 次,下调 5 次
Date 日期Broker 券商Analyst 分析师From 原评级To 新评级
25 Sep 2025华鑫证券胡博新Outperform 增持▲Buy 买入
30 Mar 2023华鑫证券胡博新,俞家宁Buy 买入▼Outperform 增持
16 Aug 2021东莞证券魏红梅Outperform 增持▲Buy 买入
8 Jun 2021东莞证券魏红梅Buy 买入▼Outperform 增持
27 Apr 2021山西证券刘建宏Outperform 增持▲Buy 买入
12 Mar 2021华鑫证券杜永宏,陈成Outperform 增持▲Buy 买入
29 Oct 2020新时代证券沈瑞Buy 买入▼Outperform 增持
28 Oct 2020华鑫证券杜永宏Buy 买入▼Outperform 增持
27 Mar 2020粤开证券李志新Outperform 增持▲Buy 买入
24 Oct 2019民生证券孙建Outperform 增持▲Buy 买入
7 Mar 2019联讯证券李志新Outperform 增持▲Buy 买入
9 Jul 2018国金证券李敬雷Outperform 增持▲Buy 买入
19 Nov 2017民生证券肖汉山Buy 买入▼Outperform 增持
25 Oct 2017东吴证券焦德智,全铭Outperform 增持▲Buy 买入
25 Apr 2017西南证券朱国广,陈铁林Outperform 增持▲Buy 买入

Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。

Current Coverage 当前覆盖
Broker 券商Analyst 分析师Latest Rating 最新评级Date 日期Reports 研报Target 目标价
国金证券马居东Buy 买入2 Sep 20261—
西南证券杜向阳,雷瑞Unrated30 Apr 20261—
华鑫证券胡博新Buy 买入25 Sep 20251—

Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 3 reports. 每行为该券商近十二个月的最新研报;3 份中 0 份给出目标价。

Coverage by Quarter 覆盖变化
4 23Q4
3 24Q1
1 24Q2
1 24Q3
1 24Q4
0 25Q1
1 25Q2
2 25Q3
0 25Q4
0 26Q1
1 26Q2
1 26Q3

Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数,最近一个季度尚未结束。